ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NovaLead Pharma to conduct Phase 3 trial for its repurposed anti COVID-19 drug
May 15, 2020In a comparable viral assay study conducted by reputed laboratories in South Korea and United States, the drug, NLP21 has shown better viral inhibition ability than Remdesivir, Fevipiravir, Hydroxychloroquine, Lopinavir/Ritonavir etc. -
Computational methodologies can be effective in predicting and prioritising key targets related to COVID
April 14, 2020NovaLead Pharma, a Pune-based company has utilised its experience of drug repurposing has deployed computational technology to identify 42 existing drugs which may be potentially effective against the SARS-Cov2 virus.
Pharma Sources Insight January 2025
